← Evidence map

TrialThe oncologist2013

AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors.

Elizabeth R Plimack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

70 papers cite itlatest 60 shown

2013
…
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23847256